181 related articles for article (PubMed ID: 9916472)
1. Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy.
Romano C; Miracco C; Difonzo EM
Mycoses; 1998 Nov; 41(9-10):433-7. PubMed ID: 9916472
[TBL] [Abstract][Full Text] [Related]
2. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Ranawaka RR; Nagahawatte A; Gunasekara TA
Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
[TBL] [Abstract][Full Text] [Related]
3. Interdigital intertrigo of the feet due to therapy-resistant Fusarium solani.
Romano C; Presenti L; Massai L
Dermatology; 1999; 199(2):177-9. PubMed ID: 10559592
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
[TBL] [Abstract][Full Text] [Related]
5. Nondermatophytic onychomycosis by Fusarium oxysporum in an immunocompetent host.
Shah SR; Dalal BD; Modak MS
J Mycol Med; 2016 Mar; 26(1):e18-21. PubMed ID: 26852190
[TBL] [Abstract][Full Text] [Related]
6. Onychomycosis caused by Alternaria spp. in Tuscany, Italy from 1985 to 1999.
Romano C; Paccagnini E; Difonzo EM
Mycoses; 2001 May; 44(3-4):73-6. PubMed ID: 11413926
[TBL] [Abstract][Full Text] [Related]
7. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
9. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Heikkilä H; Stubb S
Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
13. Onychomycosis caused by Fusarium proliferatum.
Hattori N; Shirai A; Sugiura Y; Li W; Yokoyama K; Misawa Y; Okuzumi K; Tamaki K
Br J Dermatol; 2005 Sep; 153(3):647-9. PubMed ID: 16120158
[TBL] [Abstract][Full Text] [Related]
14. Onychomycosis--treatment, relapse and re-infection.
Hull PR
Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
[TBL] [Abstract][Full Text] [Related]
15. Unusual clinical features of fingernail infection by Fusarium oxysporum.
Gianni C; Cerri A; Crosti C
Mycoses; 1997 Dec; 40(11-12):455-9. PubMed ID: 9470412
[TBL] [Abstract][Full Text] [Related]
16. A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
Takahata Y; Hiruma M; Sugita T; Muto M
Mycoses; 2008 Mar; 51(2):170-3. PubMed ID: 18254756
[TBL] [Abstract][Full Text] [Related]
17. Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.
Verrier J; Bontems O; Baudraz-Rosselet F; Monod M
Dermatology; 2014; 228(3):225-32. PubMed ID: 24603371
[TBL] [Abstract][Full Text] [Related]
18. Plantar infection by Scopulariopsis brevicaulis.
Ginarte M; Pereiro M; Fernández-Redondo V; Toribio J
Dermatology; 1996; 193(2):149-51. PubMed ID: 8884156
[TBL] [Abstract][Full Text] [Related]
19. Onychomycosis: treatment perspective.
Jain S; Sehgal VN
Int J Dermatol; 2000 Jan; 39(1):10-4. PubMed ID: 10651956
[No Abstract] [Full Text] [Related]
20. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
Elewski BE
Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
